• We specialize in small molecule inhibitors, agonists, antagonists and screening libraries!
Search Site


Bcl-Abl is a constitutively activated chimeric tyrosine kinase which is the genetic abnormality expressed in patient with CML (chronic myeloid leukemia).


  1. Cat.No. Product Name Information
  2. A3373 DPH c-ABL activitor
  3. A8812 PD173955 Dual Src/Abl kinase inhibitor, ATP-competitive,
  4. A8607 PPY A Abl kinases inhibitor
  5. A8606 PD 180970 P210bcr/abl tyrosine kinase inhibitor
  6. A8605 1-Naphthyl PP1 Src family kinases inhibitor
  7. A8604 GNF 5 Bcr-Abl inhibitor
  8. A8603 GNF 2 Bcr-Abl inhibitor
  9. A8602 Adaphostin P210bcr/abl tyrosine kinase inhibitor
  10. A2133 Saracatinib (AZD0530) Top Seller Src/Abl inhibitor,potent and selective
  11. A2149 Bosutinib (SKI-606) Potent Abl/Src kinases
  12. C5826 AG957 a tyrphostin that targets transforming Bcr-Abl fusion proteins
  13. C3677 PD 166326 receptor tyrosine kinases inhibitor
  14. B8012 ON 146040 dual PI3K and BCR-ABL inhibitor
  15. B1402 GZD824 Bcr-Abl inhibitor,novel orally bioavailable
  16. A5467 Ponatinib (AP24534) pan-BCR-ABL inhibitor,multi-kinase inhibitor
  17. A1805 Imatinib Mesylate (STI571) Top Seller Abl/c-kit/PDGFR inhibitor
  18. A8232 Nilotinib(AMN-107) Top Seller Bcr-Abl kinase inhibitor,selective
  19. A3660 Nilotinib monohydrochloride monohydrate Bcr-Abl inhibitor
  20. A3017 Dasatinib (BMS-354825) Top Seller Src and BCR-Abl inhibitor
  21. B1011 Bafetinib (INNO-406) Bcr-Abl/Lyn tyrosine kinase inhibitor
  22. B1404 DCC-2036 (Rebastinib) Bcr-Abl inhibitor